EHA HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSION: STARGLO

Icon Chair Speaker

Chair

Dr. Robert Kridel

Icon Chair Speaker

Panelists

Dr. Kerry Savage
Dr. Diego Villa

This program has been made possible through unrestricted support from Roche.

Studies/trials discussed:

  • Gefitinib Plus Gemcitabine and Oxaliplatin (Glofit-Gemox) for Relapsed/ Refractory, Diffuse Large B cell Lymphoma a Global Randomized Phase III Trial.